News

The US Food and Drug Administration (FDA) has instructed all GLP-1 drug-makers to update their warning labels to include the ...
Arch Biopartners has initiated subject recruitment in its Phase II study aimed at assessing cilastatin’s efficacy in ...
Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) announced today that the ...
A joint report by the World Health Organization (WHO) and the United Nations Office on Drugs and Crime (UNODC) has ...
Three critically ill patients treated with procizumab experience a full reversal of cardiogenic shock in 48 hours.
Hypertension affects 6% of all children and adolescents and is increasing in prevalence. Research clarifies the long-term kidney consequences.
While hydroxychloroquine (HCQ) helps reduce disease flares in lupus, its effect on renal function in patients with lupus ...
Researchers discovered that mitochondria-rich extracellular vesicles (Ti-mitoEVs) from skeletal muscle can deliver healthy ...
Predencia Wafula was thrilled to secure a job in Canada and was preparing for her journey when she suddenly fell ill and was diagnosed with kidney failure.
At the HIMSS APAC 2025 conference, GuidelineX made a powerful impact with its next-generation, AI-native Clinical Decision ...
A machine learning model may help predict mortality for hospitalized patients with cirrhosis at the time of admission, ...
USA: A recent study published in JAMA Network Open has found that the use of glucagon-like peptide-1 (GLP-1) receptor ...